Canadian Markets closed

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
0.51+0.01 (+3.03%)
At close: 3:57PM EDT
Full screen
Previous Close0.50
Open0.51
Bid0.49 x 0
Ask0.51 x 0
Day's Range0.51 - 0.51
52 Week Range0.34 - 1.90
Volume5,000
Avg. Volume49,453
Market Cap10.35M
BetaN/A
PE Ratio (TTM)-1.09
EPS (TTM)-0.47
Earnings DateNov 27, 2015 - Nov 30, 2015
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
  • RepliCel Retains Hybrid Financial for Investor Relations
    CNW Group2 days ago

    RepliCel Retains Hybrid Financial for Investor Relations

    RepliCel Retains Hybrid Financial for Investor Relations

  • PR Newswire2 days ago

    RepliCel Retains Hybrid Financial for Investor Relations

    VANCOUVER, Sept. 22, 2017 /PRNewswire/ - RepliCel Life Sciences Inc. (REPCF) (RP.V) (P6P2.F) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that it has retained Hybrid Financial Inc. ("Hybrid") to provide certain investor relations services (the "Services") to the Company, commencing September 26, 2017. Under the terms of Hybrid's engagement (the "Engagement"), RepliCel has agreed to pay Hybrid a monthly retainer of CAD$15,000 for an initial term of six months, with such retainer payable upon completion of RepliCel's next financing. Upon completion of the initial six-month term, RepliCel may extend the term of the Engagement on a month-to-month basis.

  • CNW Group12 days ago

    RepliCel's Partnership Initiatives Mature into Licensing Negotiations

    RepliCel's Partnership Initiatives Mature into Licensing Negotiations